Course Description
Although serum β-human chorionic gonadotropin testing is the most accurate means of confirming a pregnancy, it is unable to provide important anatomical and structural details about early gestation. To this end, sonography has become the imaging modality of choice to help determine fetal location and morphology and identify major anomalies. The technology is widely available, cost-effective, and capable of providing real-time examination of the fetus. While sonography yields scans with greater spatial resolution than many other imaging modes, utilizing magnetic resonance imaging (MRI) in early pregnancy can also assist with visualizing detailed anatomical features of the fetus. Current indications for the use of sonography and MRI during the first trimester have been promulgated by a variety of professional societies and underscore the recognition that evaluating fetal anatomy during early development is of great importance. Timelines of findings and biometric measurements for dating have been established, along with sonographic features characteristic of normal and abnormal intrauterine pregnancies. This information can greatly aid in patient decision-making, especially during the first trimester, when the option of terminating pregnancies due to major anomalies is most readily exercised.

Learning Objectives
After reading this article, the participant should be able to:

• ASSESS the current recommendations for the use of sonography and magnetic resonance imaging in first trimester obstetrics.
• IDENTIFY the key anatomic landmarks and their timing of visualization in normal intrauterine pregnancy.
• DISTINGUISH common fetal anomalies and abnormalities detectable via high-resolution transvaginal sonography.
  

Categories: Ultrasound/sonography, MRI

In order to receive CE credit, you must first complete the activity content. When completed, go to the "Take CE Test!" link to access the post-test.

Submit the completed answers to determine if you have passed the post-test assessment. You must answer 6 out of 8 questions correctly to receive the CE credit. You will have no more than 3 attempts to successfully complete the post-test.

Participants successfully completing the activity content and passing the post-test will receive 1.0 ARRT Category A credit.

Approved by the American Society of Radiologic Technologists for ARRT Category A credit.

Approved by the state of Florida for ARRT Category A credit.

Texas direct credit.

This activity may be available in multiple formats or from different sponsors. ARRT does not allow CE activities such as Internet courses, home study programs, or directed readings to be repeated for CE credit in the same biennium.

For ACCME Credit Provided by AKH Inc.

Release Date: 7/7/2021

Expiration Date: 7/7/2023

Target Audience
This activity is designed to meet the needs of Radiologic Technologists and Physicians, specifically Radiologists.

Method of Participation
In order to receive credit, participants should complete the pre-test, review the content, and continue to the post-test and evaluation. A certificate will generate upon successful submission of the post-test and evaluation. If you have questions about this CME activity, please contact AKH Inc. at jgoldman@akhcme.com.

CE credit provided by AKH Inc., Advancing Knowledge in Healthcare.  This activity is jointly-provided by AKH Inc., Advancing Knowledge in Healthcare and eRADIMAGING.

In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and eRADIMAGING. AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians
AKH Inc., Advancing Knowledge in Healthcare designates this enduring activity for a maximum of 1.0  AMA PRA Category 1 Credit^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Commercial Support
There is no commercial support for this activity.

Disclosures
None of the planners or faculty for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The planners and faculty must disclose to the participants any significant relationships with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients." or with the commercial supporter of this accredited continuing education activity. Identified conflicts of interest are mitigated by AKH prior to the planners/faculty assuming their role in this accredited continuing education activity.

Disclosure of Unlabeled Use and Investigational Products
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaims responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participant's misunderstanding of the content.